Antithrombotic & Anticoagulant Therapy with Cardiac Devices
Pharmacy to Dose: The Critical Care Podcast
Is There Evidence for Non Warfer Based Anticoagulation Regimens?
Tiller studied to do astrn, 81 milligrams daily. Prus war fern for at least forty five days o tenitud with anine ar two to three. In ultimate forty five days, around that point, you do a t e e. And if there's no partiv ice lef, no large leap or anything is there, then they go on dap for six months. None of those turned in stroke. The risk of device based by mosis was clearly the highest. A one point three % risk of device were laid at broun bosas. But all these patients, and that thoug roal rate was low, one point three%.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
